Previous 10 | Next 10 |
Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials PR Newswire DUBLIN , March 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping premixed...
The shares of pharmaceutical company Endo International (ENDP) have plunged more than 50% in price over the past three months despite the company reporting mixed financial numbers in its last quarterly earnings release. In addition, considering that several analysts have lowered their price t...
While maintaining a buy rating, Citi has cut its price target on Endo International (NASDAQ:ENDP) to $6 from $11 (~165% upside based on Tuesday's close). Analyst Navann Ty said that after a follow-up meeting with the company, the firm is lowering its 2022 revenue estimate by 5% and EPS by 17%...
Entrance of generic competitor to Vasostrict materially hurting revenue. QWO uptake seems slow with concerns around discoloration side-effect. Q1 guide implies leverage rising dangerous levels. Bankruptcy seems like an increasingly likely option. For further details see:...
Endo Launches New Living Our Values Program to Recognize Outstanding Team Members Canada NewsWire DUBLIN , March 3, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) today honored select team members from across the world who exemplify Endo's Values as par...
John Paulson’s 13F portfolio value decreased from $3.51B to $3.24B this quarter. Paulson & Company increased Pacira Biosciences and SSR mining while reducing Brightsphere Investment Group and Thryv Holdings. The top three positions are at 49% of the portfolio. For...
Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events PR Newswire DUBLIN , March 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) has kicked off a series of...
Barclays has downgraded Endo International (NASDAQ:ENDP) to underweight from equal weight citing three headwinds the company faces this year. The firm also lowered its price target to $2 from $5 (~17% downside from Tuesday's close). Analyst Balaji Prasad said that those headwinds are: lowered...
Shares of Endo International (NASDAQ: ENDP) dropped 22.8% on Tuesday. The stock had closed at $3.11 on Monday and then opened at $2.83 on Tuesday before hitting a low of $2.40 in early trading. The stock is down more than 36% this year and more than 63% over the past 12 months, with...
Endo International plc (ENDP) Q4 2021 Earnings Conference Call March 01, 2022 07:30 AM ET Company Participants Laure Park - Senior Vice President, Investor Relations and Corporate Affairs Blaise Coleman - President and CEO Mark Bradley - Executive Vice President and CFO Patrick Barry - Presid...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...